Finance

Lists
Why is KAEF down 2,48%?
Dive Deeper
KAEF:IDX
Kimia Farma (Persero) Tbk PT
IDR 394,00
-2,48%
(-10,00) 1D
13 Nov., 16:02:24 GMT+7  ·   IDR
All symbols
SymbolPriceChange% Change
Generating top insights for KAEF...
Open
IDR 402
High
IDR 420
Low
IDR 392
Mkt. cap
2,19 bn
Avg. vol.
950,06 k
Volume
702,50 k
52-wk high
IDR 785
52-wk low
IDR 324
EPS
-IDR 39
Shares outstanding
5,57 mjd
No. of employees
9 k
Open
IDR 402
High
IDR 420
Low
IDR 392
Mkt. cap
2,19 bn
Avg. vol.
950,06 k
Volume
702,50 k
52-wk high
IDR 785
52-wk low
IDR 324
EPS
-IDR 39
Shares outstanding
5,57 mjd
No. of employees
9 k
News stories
From web sources and news partners
Profile
PT Kimia Farma Tbk is an Indonesian pharmaceutical producer and distributor in Indonesia. It is based in Jakarta. Wikipedia
About Kimia Farma (Persero) Tbk PT
CEO-
Employees9,22 k
Founded16 Aug. 1971
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Previous reportsAll values in IDR
Loading Previous Earnings...
Revenue
Net income
All values in IDR
Des. 2025
Mrt. 2026
Jun. 2026
Sep. 2026
Revenue
2,22 bn
2,03 bn
2,67 bn
2,37 bn
Cost of goods sold
1,56 bn
1,29 bn
1,86 bn
1,58 bn
Cost of revenue
1,56 bn
1,29 bn
1,86 bn
1,58 bn
Research and development expenses
7,54 mjd
3,20 mjd
10,39 mjd
8,30 mjd
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
663,87 mjd
640,94 mjd
620,33 mjd
611,55 mjd
Operating expense
877,17 mjd
669,20 mjd
722,39 mjd
720,62 mjd
Total operating expenses
2,44 bn
1,96 bn
2,59 bn
2,30 bn
Operating income
-222,99 mjd
67,93 mjd
84,77 mjd
69,64 mjd
Other non operating income
173,66 mjd
159,00 mjd
-26,56 mjd
-10,68 mjd
EBT including unusual items
-223,75 mjd
127,96 mjd
-60,16 mjd
-57,52 mjd
EBT excluding unusual items
-260,76 mjd
127,95 mjd
-60,19 mjd
-63,66 mjd
Income tax expense
-14,50 mjd
4,32 mjd
9,40 mjd
9,47 mjd
Effective tax rate
6,48%
3,37%
-15,62%
-16,46%
Other operating expenses
-36,20 mjd
-12,78 mjd
-9,74 mjd
6,41 mjd
Net income
-155,23 mjd
74,45 mjd
-64,12 mjd
-72,34 mjd
Net profit margin
-7,01%
3,67%
-2,40%
-3,05%
Earnings per share
-
-
-
-
Interest and investment income
10,77 mjd
2,87 mjd
8,13 mjd
7,82 mjd
Interest expense
-221,53 mjd
-110,15 mjd
-125,81 mjd
-121,69 mjd
Net interest expenses
-210,75 mjd
-107,28 mjd
-117,68 mjd
-113,87 mjd
Depreciation and amortization charges
175,98 mjd
37,85 mjd
101,42 mjd
81,08 mjd
EBITDA
-86,40 mjd
125,64 mjd
165,62 mjd
155,10 mjd
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google-programme